Using AI to Improve Diagnosis of Disease

Using AI to Improve Diagnosis of Disease

Episode 166

The power of artificial intelligence and machine learning looms over medtech as a growing force that will bring change, good or bad.

While tech giants like Google, Apple, and IBM circle high above, start-ups such as IDx are close to bringing AI into the physician’s office with AI-supported diagnostic tools.

In this OIS Podcast, Michael Abramoff, MD, PhD, president, director and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.

If approved, IDx will be positioned to diagnose patients with the dangerous disease much earlier, giving them a chance to see an ophthalmologist and start treatment earlier to save their sight, Dr. Abramoff says.

The company also sees its system as a way to diagnose other diseases, including glaucoma and age-related macular degeneration. “The opportunity for dragging down costs is enormous,” he states.

Dr. Abramoff founded the company over a decade ago, long before tech companies showed a strong interest in AI’s role in healthcare. Now, IDx is working with one – IBM Watson Health – to facilitate the marriage of both.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our Host

TOM SALEMI

Tom-Salemi

Joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.